Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study
This study highlights interrelated factors contributing to the limited adoption of biosimilar insulin in Europe. Addressing these barriers through targeted policy interventions may support more informed decision making and facilitate biosimilar insulin adoption in the future.
Authors
- Arnold G. Vulto (ORCID: https://orcid.org/0000-0002-8439-2800)
- Steven Simoens (ORCID: https://orcid.org/0000-0002-9512-2005)
- Elif Car (ORCID: https://orcid.org/0000-0003-4356-4722)
- Lutz Heinemann (ORCID: https://orcid.org/0000-0003-2493-1304)
- Isabelle Huys (ORCID: https://orcid.org/0000-0002-4738-8298)
- Garm Habets
Institutions
- Erasmus MC (NL)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Erasmus University Rotterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/dom.70082
- Citations
- 1
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- KU Leuven